Intrahepatic cholangiocarcinoma.

Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population. Int J Clin Exp Pathol (2014) 0.82

Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Oncol (2015) 0.82

Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature. Diagn Pathol (2015) 0.78

Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. World J Gastroenterol (2016) 0.76

Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr (2017) 0.75

Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases. Cancer Biol Med (2016) 0.75

Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther (2017) 0.75

Recurrent Cardiac Tamponade: An Unusual Presentation of Intrahepatic Cholangiocarcinoma. ACG Case Rep J (2016) 0.75

Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma. Oncol Lett (2017) 0.75

Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc (2015) 0.75

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71

Biliary tract cancers. N Engl J Med (1999) 6.36

The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (2001) 5.12

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg (2008) 3.16

Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology (2009) 3.03

Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg (2007) 2.67

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology (2011) 2.63

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg (2002) 2.62

Worldwide trends in mortality from biliary tract malignancies. BMC Cancer (2002) 2.61

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57

Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery (2000) 2.55

Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2011) 2.51

Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42

Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42

Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33

Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol (2013) 2.16

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg (2007) 1.87

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84

Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol (2000) 1.79

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72

A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol (2008) 1.64

Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol (2011) 1.61

Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg (2003) 1.59

Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46

AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer (2010) 1.44

Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology (2000) 1.43

Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg (2005) 1.39

Laparoscopic liver resection. World J Surg (2011) 1.38

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol (2009) 1.34

Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc (2006) 1.28

An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery (2004) 1.26

Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg (2009) 1.25

Comparison of laparoscopic versus open liver tumor resection: a case-controlled study. Surg Endosc (2008) 1.24

Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery (1992) 1.23

Laparoscopic versus open liver resection: a matched-pair case control study. J Gastrointest Surg (2009) 1.23

Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg (2007) 1.19

Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc (1993) 1.15

Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology (2005) 1.12

Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc (2012) 1.11

Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2008) 1.10

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging (2003) 1.10

FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun (2001) 1.10

Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol (2011) 1.09

Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery (2007) 1.07

The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. Hepatogastroenterology (2002) 1.06

Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg (2007) 1.05

What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol (2007) 1.04

Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. Int J Cancer (2011) 1.04

Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr (1999) 1.03

Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg (1998) 1.03

Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03

Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg (2012) 1.02

Liver transplantation for perihilar cholangiocarcinoma. Dig Dis (2013) 1.02

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00

Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg (2007) 0.99

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep (2013) 0.98

Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl (2005) 0.98

Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer (1991) 0.97

Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg (2011) 0.95

Minimally invasive liver resection: robotic versus laparoscopic left lateral sectionectomy. J Gastrointest Surg (2012) 0.91

Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol (2009) 0.91

Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg (2003) 0.90

The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am (2007) 0.89

Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg (2011) 0.88

Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87

Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg (2011) 0.87

A current update on the evolution of robotic liver surgery. Minerva Chir (2011) 0.87

Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology (1997) 0.86

Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86

Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol (2005) 0.85

Role of major vascular resection in patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol (2012) 0.80

Peripheral cholangiocarcinoma: sonographic evaluation. J Clin Ultrasound (1992) 0.78

Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound (1998) 0.76